Genfit (GNFT) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free GNFT Stock Alerts $3.66 +0.16 (+4.57%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGenfit (NASDAQ:GNFT) Stock Price Up 1.2%marketbeat.com - April 27 at 12:47 AMGENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)globenewswire.com - April 25 at 4:10 PMGENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documentsglobenewswire.com - April 15 at 4:10 PMGENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-Fglobenewswire.com - April 5 at 2:00 PMGenfit's (GNFT) Buy Rating Reiterated at HC Wainwrightmarketbeat.com - April 5 at 8:28 AMGENFIT S.A.: GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - April 5 at 4:56 AMGENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - April 4 at 4:10 PMEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Tradingmsn.com - April 3 at 12:51 PMGenfit S.A. (NASDAQ:GNFT) Short Interest Updatemarketbeat.com - April 2 at 10:00 AMEuropean Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Tradingmsn.com - March 27 at 1:06 PMGenfit S.A. (NASDAQ:GNFT) Sees Large Increase in Short Interestmarketbeat.com - March 5 at 1:23 PMGENFIT Announces Revenues and Cash Position as of December 31, 2023globenewswire.com - February 29 at 4:10 PMGENFIT S.A.thestreet.com - February 25 at 1:21 PMInventiva drops after adverse event in Phase 3 trial for NASH drugmsn.com - February 16 at 3:02 PMEquities Analysts Issue Forecasts for Genfit S.A.'s FY2026 Earnings (NASDAQ:GNFT)marketbeat.com - February 8 at 8:54 AMLeerink Partnrs Research Analysts Boost Earnings Estimates for Genfit S.A. (NASDAQ:GNFT)marketbeat.com - February 7 at 8:37 AMEuropean Equities Traded in the US as American Depositary Receipts Kick Off Week Lower in Monday Tradingmsn.com - February 5 at 12:50 PMEuropean Equities Traded in the US as American Depositary Receipts Trend Lower in Monday Tradingmsn.com - January 29 at 1:31 PMGenfit S.A. (NASDAQ:GNFT) Short Interest Down 8.5% in Decembermarketbeat.com - January 4 at 8:22 AMGenfit Stock (NASDAQ:GNFT) Dividends: History, Yield and Datesbenzinga.com - December 21 at 3:56 PMGenfit SA ADR GNFTmorningstar.com - December 20 at 12:33 AMFDA grants priority review of Genfit-Ipsen liver disease drugmsn.com - December 7 at 7:56 AMIpsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBCmarkets.businessinsider.com - December 7 at 2:56 AMGENFIT Highlights ACLF Development Strategy at "ACLF Day" during AASLD The Liver Meeting® 2023benzinga.com - November 17 at 9:05 AMGENFIT Reports Third Quarter 2023 Financial Informationfinance.yahoo.com - November 9 at 6:14 PMOil Stocks Buoy European Equities Traded in the US as American Depositary Receipts Thursdaymsn.com - November 9 at 1:13 PMOil Stocks Burden European Equities Traded in the US as American Depositary Receipts Tuesdaymsn.com - November 7 at 12:41 PMGENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technologyfinance.yahoo.com - September 26 at 8:22 PMGENFIT S.A. Unsponsored ADR (GNFT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Nowfinance.yahoo.com - September 26 at 3:22 PMGENFIT S.A.: GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - September 22 at 9:33 AMGENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - September 20 at 7:19 PMGenfit (NASDAQ: GNFT)fool.com - September 15 at 7:44 PMFY2024 Earnings Forecast for Genfit S.A. (NASDAQ:GNFT) Issued By Leerink Partnrsmarketbeat.com - August 28 at 2:54 AMEuropean Equities Traded in the US as American Depositary Receipts Higher Wednesdaymsn.com - August 16 at 3:49 PMEuropean Equities Traded in the US as American Depositary Receipts Start Week on Down Notemsn.com - August 14 at 4:03 PMGenfit’s Liver Disease Candidate Delivers Promising Phase 3 Resultsmsn.com - June 30 at 8:48 AMKepler Capital Keeps Their Buy Rating on Genfit (GNFTF)markets.businessinsider.com - June 16 at 12:28 AMPORTZAMPARC BNP PARIBAS Maintains Genfit (EPA:GNFT) Buy Recommendationmsn.com - June 8 at 8:33 AMGENFIT Announces New Data at the European Association for the Study of the Liver (EASL) Congress 2023finance.yahoo.com - June 7 at 5:32 PMO Shaughnessy Asset Management LLC Trims Stock Holdings in Genfit S.A. (NASDAQ:GNFT)marketbeat.com - June 4 at 5:44 AMAnalysts Offer Insights on Healthcare Companies: Coherus Biosciences (CHRS) and Genfit SA (GNFT)markets.businessinsider.com - June 1 at 7:37 AMSeal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT for Development of Injectable Formulation of SRT-015 for Acute-on-Chronic Liver Disease (ACLF)finance.yahoo.com - May 31 at 9:36 PMGENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Assetfinance.yahoo.com - May 31 at 4:36 PMGENFIT Announces Publication of the Development and Validation of NIS2+™ in the Journal of Hepatologyfinance.yahoo.com - May 23 at 7:15 PMGENFIT Annual Combined General Meeting of May 24, 2023 — Availability of Preparatory Documentsfinance.yahoo.com - April 19 at 5:42 PMGENFIT to Participate in Upcoming Investor Conferencesfinance.yahoo.com - January 5 at 5:52 PMGenfit S.A. (NASDAQ:GNFT) Sees Significant Drop in Short Interestmarketbeat.com - October 30 at 11:15 AM12 Health Care Stocks Moving In Monday's Pre-Market Session - Acer Therapeutics (NASDAQ:ACER), Avadel Pha - Benzingabenzinga.com - October 10 at 1:07 PMGENFIT : Pipeline Day - Corporate Presentation - October 2022 - Marketscreener.commarketscreener.com - October 7 at 7:33 AMGENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis - GlobeNewswireglobenewswire.com - September 30 at 1:04 AM Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. GNFT Media Mentions By Week GNFT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNFT News Sentiment▼0.000.42▲Average Medical News Sentiment GNFT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNFT Articles This Week▼00▲GNFT Articles Average Week Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Elevation Oncology News Kodiak Sciences News Compugen News Zura Bio News Innate Pharma News X4 Pharmaceuticals News Century Therapeutics News Acumen Pharmaceuticals News Cardiff Oncology News Compass Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNFT) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genfit S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
